Clinical Trial Update: HIV Diversity and Pathogenesis in Donor-Recipient Clusters

View source ↗

Summary

A completed NHLBI clinical trial update examining HIV diversity and pathogenesis in donor–recipient clusters.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Acquired Immunodeficiency Syndrome, Blood Transfusion | Status: COMPLETED